Biotech Daily Market Report November 28, 2006
November 28th 2006 07:12
ASX FALLS, BIOTECHS STEADY:
PHYLOGICA UP 16% TISSUE THERAPIES DOWN 6%
PHYLOGICA UP 16% TISSUE THERAPIES DOWN 6%
THE MARKET
The Australian stock market was fell 1.2 percent on Tuesday November 28, 2006, with the All Ordinaries down 64.7 points to 5,367.8 points.
Nineteen of the Biotech Daily Top 40 stocks were up, 19 stocks fell, two traded unchanged and none were untraded. Nine of the Top 20 rose and 10 fell, while 10 of the Second 20 rose and nine fell.
Phylogica was best on small volumes climbing 4.5 cents or 16.07 percent to 32.5 cents, followed by Bionomics up 1.5 cents or 7.89 percent to 20.5 cents, Polartechnics up half a cent or 5.26 percent to 10 cents on modest volumes and Biota up 7.5 cents or 5.19 percent to $1.52 with 1.2 million shares traded. Metabolic was up half a cent or 0.6 percent to 84.5 cents with 1.5 million shares changing hands.
Genetic Technologies jumped 4.0 percent on small volumes; Prana and Psivida were both up more than three percent; Avexa, Optiscan and Uscom were up more than two percent; with Peptech, Phosphagenics, Prima and Proteome climbing more than one percent.
Tissue Therapies fell furthest, down three cents or 6.25 percent to 45 cents on small volumes, followed by Portland down two cents or 5.26 percent to 36 cents and Living Cell down one cent or 5.0 percent to 19 cents.
Agenix, Evogenix and Novogen were down more than four percent; Clinical Cell and CSL fell more than three percent; Biosignal, Clinuvel, Cochlear and Neuren were down more than two percent; with Acrux, Alchemia, Cellestis, Chemgenex, Cygenics, Cytopia and Mesoblast down more than one percent.
TODAY'S NEWS
* VIROSOME BUY SHRINKS NORWOOD ABBEY HOLD ON IMMUNOLOGY
* USCOM ROADSHOW
* BIOPHARMICA'S DR SAM GALLAGHER SURRENDERS DIRECTORSHIP
To view these articles readers need to subscribe to Biotech Daily.
See details at www.biotechdaily.com.au
| 30 |
| Vote |
Add To: 
subscribe to this blog